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Background: The ‘Parsonage-Turner syndrome’ (PTS) is a rare but distinct disorder with an abrupt onset of
shoulder pain, followed by weakness and atrophy of the upper extremity musculature, and a slow recovery
requiring months to years. To our best knowledge, this is the first case describing symptoms and signs of PTS
following the administration of a post-exposure prophylaxis (PEP) regimen against possible human immunodeficiency
virus (HIV) and hepatitis B virus (HBV) infection.
Case presentation: A 25-year-old Caucasian man presented with pain and unilateral scapular winging following PEP
against possible HIV and HBV infection. Although atrophy and weakness were observed for the right supraspinatus
muscle, a full range of motion was achievable. Neurological examination, plain radiography of the right shoulder and
electromyography showed no additional abnormalities. The patient was diagnosed with post-vaccination PTS and
treated non-operatively. During the following 15 months the scapular winging receded and full muscle strength was
regained.
Conclusion: Parsonage-Turner syndrome is a rare clinical diagnosis. The precise pathophysiological mechanism of PTS
remains unclear, but it seems to involve an interaction between genetic predisposition, mechanical vulnerability and
an autoimmune trigger. An immunological event, such as – in this case – a vaccination as part of PEP treatment, can
trigger the onset of PTS. The clinical presentation is distinctive with acute severe pain followed by patchy paresis,
atrophy and sensory symptoms that persist for months to years. No currently available tests can provide a definite
confirmation or exclusion of PTS. Routine blood examination, electromyography (EMG), and computed tomography
(CT) or magnetic resonance imaging (MRI) serve mainly to exclude other disorders. The recovery can be quite lengthy,
non-operative treatment is the accepted practice. Supplementary administration of oral prednisolone could shorten
the duration of pain. Although the outcome is typically preferable, a substantial amount of patients are left with some
residual paresis and functional impairment.
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The ‘Parsonage-Turner syndrome’ (PTS), ‘brachial plexus
neuritis’ or ‘neuralgic amyotrophy’ is a rare but distinct
peripheral nervous system disorder that may occur in
otherwise healthy individuals. It is named for Maurice
Parsonage and John Aldren Turner, who in 1948 reported
136 cases with a syndrome that: ‘without any constitu-
tional disturbance pain starts suddenly across the top of
the shoulder-blade and may radiate down the outer side of
the upper arm or into the neck … then a flaccid paralysis* Correspondence: c.schonhuth@vumc.nl
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reproduction in any medium, provided the orof some of the shoulder girdle … develops’ [1]. Core fea-
tures include an abrupt onset of shoulder pain (usually
unilaterally), followed by motor involvement (weakness
and atrophy) of the upper extremity musculature, and a
slow recovery requiring months to years. The extent and
distribution of affected peripheral nerves can vary greatly
[1-3]. In addition to the characteristic course of symptom-
atology, the most common tell-tale sign of the disorder is
winging of the shoulder blade, which is present in
approximately two-third of the patients [2]. The anterior
interosseus and suprascapular motor nerves and the lat-
eral antebrachial cutaneous and superficial radial sensory
nerves are frequently involved. Sensory symptoms areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Clinical presentation at first consultation. A, B & C.
Scapular winging in frontal, dorsal and sagittal plane. Photographs
were taken at the time of presentation.
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recall hypaesthesia [2,4].
Currently, no test can definitely confirm or exclude
PTS. Routine blood examinations, CT or MRI, and elec-
tromyography serve mainly to exclude other disorders.
Nerve conduction studies are of limited value in the
diagnosis of PTS [2].
The recovery rate differs, but in general patients recover
80-90% of their full strength after 2–3 years. However,
more than 70% are left with residual paresis and func-
tional impairment. These biomechanical changes increase
the risk of joint pathology and strain of the paretic and
compensating muscles [2]. Although the recovery can
be quite lengthy, non-operative treatment is the accepted
therapy. Anecdotal evidence and a single retrospective
case series show some evidence to suggest that early oral
corticosteroid therapy may have a positive influence on
pain in some patients, and possibly speed up recovery in a
few [5]. If functional impairment persists for a prolonged
period of time, surgical options have been described [6,7].
The precise pathophysiological mechanism remains
unclear, but it seems to involve an interaction between an
underlying genetic predisposition, a mechanical vulnerabil-
ity and an autoimmune trigger (i.e. vaccination) [2,8].
Accurately diagnosing Parsonage-Turner syndrome can
be difficult because of its clinical presentation. We describe
a patient with PTS following the administration of post-
exposure prophylaxis against possible human immunodefi-
ciency virus and hepatitis B virus infection.
Case presentation
A 25-year-old Caucasian man was referred to our out-
patient clinic, two months after initial presentation at
the Emergency Room because of accidental exposure to
bloodborne pathogens. In accordance with the Dutch post-
exposure prophylaxis guidelines, post-exposure prophylaxis
(PEP) was indicated against possible infection with hu-
man immunodeficiency virus (HIV) and hepatitis B virus
(HBV) [9]. The patient immediately received 500 IU of hu-
man hepatitis B immunoglobulin intramuscularly into the
right shoulder, and hepatitis B vaccination according to the
vaccine dose schedule, at 0, 1 and 6 months. Additionally,
the patient received 4 weeks of atazanavir 400 mg with
combivir 450 mg (lamivudine/zidovudine) twice daily. Flu-
like symptoms occurred in the first week, which subse-
quently diminished. Following the second intramuscular
vaccine dose, the patient complained of neck pain, with
radiating pain towards his right shoulder. The patient
noticed a deviated position of his right scapula. During the
next weeks the pain gradually subsided, but the scapular
deviation persisted. No subjective signs of muscle weak-
ness or sensory symptoms were present.
On physical examination, the patient had evident scapu-
lar winging (Figures 1A-C). Atrophy and weakness wereobserved for the right supraspinatus muscle. However, a full
range of motion was achievable. Thorough neurological
examination did not indicate any further deficits. Plain radi-
ography of the right shoulder showed no abnormalities.
Electromyography (EMG) recorded two months after initial
presentation, showed no neuromuscular abnormalities of
the long thoracic or suprascapular nerve.
The clinical diagnosis ‘Parsonage-Turner syndrome’ was
made. The patient received non-operative treatment. The
scapular winging receded during the following 15 months
(Figures 2A-C and 3A-C). Full muscle strength was regained.
The HIV and HBV serology proved to be negative.
Figure 2 Clinical presentation after 3 months. A, B & C. Scapular
winging and atrophy of the supraspinatus muscle. Photographs
were taken three months after initial presentation.
Figure 3 Clinical presentation after 15 months. A, B & C.
Complete recovery of scapular winging and no residual atrophy.
Photographs were taken fifteen months after initial presentation.
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Clinical presentation
Parsonage-Turner syndrome is a clinical diagnosis and
presents in 96% of the cases with acute, severe neurologic
pain in the upper extremities, neck and/or trunk, without
any antecedent trauma. The pain usually causes the patient
to wake up early in the morning, and lasts for 4 weeks on
average, but disappears within 24 hours in 5% of the cases.
In addition to the pain, there is a patchy distribution of
motor and sensory symptoms. The most frequently in-
volved nerves are: long thoracic nerve, anterior interosseusnerve, suprascapular nerve, lateral antebrachial cutaneous
nerve and superficial radial nerve. Involvement of the long
thoracic nerve leads to weakness of the serratus anterior
muscle and winging of the scapula [2]. It can take quite
some time to arrive at the proper diagnosis, with a median
period to diagnosis of 10.5 weeks. The difficulty lies with
the recognition of the clinical entity of Parsonage-Turner
syndrome, especially when patients present without the
indicative scapular winging [4]. Table 1 presents the dif-
ferential diagnosis of PTS includes pathology of both
orthopaedic and neurological nature, based on van Alfen
et al. [2].
Table 1 The differential diagnosis of Parsonage-Turner syndrome, based on Van Alfen et al. [2]
Orthopaedic disorders Distinguishing features
Rotator cuff pathology Subacute or insidious onset, pain intensity varies, worsens with motion, weakness, progressive
Adhesive capsulitis Subacute onset, pain, ‘frozen shoulder’, limited range of motion (active and passive), progressive
Subacromial bursitis Subacute onset, pain along front and side, nighttime pain, painful arc of motion, fluctuating course
Calcific tendinitis Subacute onset, pain, worsens with elevation, sometimes stiffness, self-limiting
Osteoarthritis Insidious onset, pain, worsens with motion, stiffness, secondary weakness, slowly progressive
Facioscapulohumeral dystrophy Onset during adolescence, facial weakness, weakening biceps/triceps/deltoids, hearing loss, painless, progressive
Cervical spondylosis with referred
brachialgia
Often posture or activity dependent, no neurological deficits, fluctuating course
(Primary) tumors of the scapula Non acute onset, scapular winging without weakness and no neurological symptoms
Neurological disorders Distinguishing features
Cervical radiculopathy,
degenerative
Insidious onset, slowly progressive or fluctuating course
Cervical radiculopathy, discrupture Acute onset, pain varies with posture: pain, sensory and motor symptoms occur in the same dermatome
Mononeuritis multiplex/vasculitis Symptoms also occur in legs or distal arm, subacute onset, progressive
Multifocal motor neuropathy Painless, no sensory symptoms, distal predominance, progressive
Asian tick-borne encephalitis
(poliomyelitic)
Following viral prodrome, severe headache and back pain, flaccid shoulder girdle paralysis
Focal motor neuron disease Insidious onset, no sensory symptoms, painless, progressive
Entrapment neuropathies Subacute onset, mild to moderate pain, prominent sensory symptoms
Other disorders Distinguishing features
Complex regional pain syndrome Subacute onset, vasomotor features predominate, diffuse pain and weakness, progressive
Lyme disease Subacute onset, swelling, pain, rash, fever, fatigue, fluctuating course
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No currently available tests can provide a definite confirm-
ation or exclusion of PTS. Routine blood examination, elec-
tromyography (EMG), and computed tomography (CT) or
magnetic resonance imaging (MRI) serve mainly to exclude
other disorders such as cervical disc herniation, rotator cuff
pathology or neoplasms. Both EMG and MRI must be
interpreted with consideration of the clinical history.
The use of brachial plexus sensory nerve conduction
studies seem to be of little diagnostic value in Parsonage-
Turner syndrome. Sensory symptoms occur in 80% of the
patients, sensory nerve conduction studies showed abnor-
malities in less than 20% of nerves, even when the nerve
was clinically affected. This could be due to some sensory
lesions in the nerve roots instead of the plexus. An exam-
ination of normal sensory nerve conduction studies does
not rule out PTS as a diagnosis [10].
The MRI finding most typical of PTS is that of diffuse
high signal intensity involving one or more muscles in-
nervated by the brachial plexus depicted on T2-weighted
images. This is thought to reflect denervation injury, with
the signal intensity increase due to increased capillary
blood volume in partially denervated muscle. In addition,
T1-weighted images can show focal fatty atrophy in about
30% of the cases. However, both findings are not specificfor PTS, but can also be caused by trauma, entrapment
neuropathy and herniated cervical discs [11].
Treatment
During the onset of symptoms, the administration of
oral prednisolone could shorten the duration of pain
and also accelerate the recovery in some patients. A
daily dose of oral prednisolone of 1 mg/kg for one week,
in combination with a long acting opioid and a non-
steroidal anti-inflammatory drug (NSAID) (both twice
per day) can be considered [5]. The musculoskeletal pain
that ensues from altered biomechanics of the affected
extremity can be treated by a combination of physiother-
apy for posture, mobility and relaxation, and NSAIDs.
The patient should be encouraged to use the affected
extremity as fully as possible [2,5].
Although recovery can be quite lengthy, non-operative
treatment is the accepted practice. The rare patient who
doesn’t improve, may need surgical intervention [3,12].
Decompression and microneurolysis of the long thoracic
nerve in the supraclavicular spaces has shown improve-
ment with regard to scapular winging, pain reduction and
shoulder instability [13]. Another accepted surgical pro-
cedure for non-resolving scapular winging is a dynamic
muscle transfer in which the sternal head of the pectoralis
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tended or reinforced by a fascial autograft. This procedure
has shown consistently positive results with improved
function, resolution of winging, and relief of pain [6,7].
Outcome
The severity of onset, development and extent of recovery
can vary between patients. Overall, most patients recover
80-90% of their full strength after 2–3 years, but more
than 70% are left with some residual paresis and func-
tional impairment. These biomechanical changes possibly
increase the risk of joint pathology and strain of the
paretic and compensating muscles [2]. Almost a third of
the patients suffer from chronic pain, and the majority
exhibits persisting functional deficits after an average
follow-up of more than six years. It is therefore recom-
mended that the attending physician communicates this
possibility with the patient at an early stage [4].
Pathophysiology
The pathophysiological mechanisms seem to involve an
interaction between an underlying genetic predispos-
ition, a mechanical vulnerability, and an autoimmune
trigger. The direct relationship between the genetic pre-
disposition and the actual onset of PTS is still unknown
[2]. Nearly 10% of the manifestations of PTS are pre-
ceded by unusual physical exercise. This role for mech-
anical factors was demonstrated during an epidemic of
PTS, which occurred when a contaminated water supply
infected hundreds of people. However, PTS mainly
occurred among workers in a nearby knitting factory,
who used their arms strenuously [14]. The onset of PTS
could be mediated by wear-and-tear-induced weakening of
the blood-nerve barrier that normally prevents any contact
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Bartonella henof the patients with PTS different types of immuno-
logical events, such as vaccination, surgery, pregnancy,
childbirth, immunotherapy and many different types of
infection, have been reported [4].
With regard to the aforementioned patient, it is most
likely that the post-exposure prophylaxis against HIV
and HBV triggered the onset of PTS, as the serology
proved to be negative for infection.
There is limited literature available concerning PTS
and HIV. One case report described the occurrence of
PTS as a rare hypersensitivity reaction of HIV-infected
patients to abacavir [15], a drug our patient did not re-
ceive. Two case reports describe the onset of PTS in the
context of acute HIV seroconversion illness [16,17]. An-
other study reports a case of varicella reactivation caus-
ing bilateral PTS in an HIV-positive patient [18].
With regard to PTS and HBV, a three-year postmarket-
ing surveillance for neurologic adverse events following
plasma derived hepatitis B vaccination (each 1.0 ml of
vaccine contained 20 μg of hepatitis-B surface antigen
(HBsAg)) was carried out in 1988 for 850.000 patients.
A total of 41 neurologic adverse events were reported:
Bell's palsy (10), Guillain-Barré syndrome (9), convulsions
(5), lumbar radiculopathy (5), optic neuritis (5), transverse
myelitis (4), and Parsonage-Turner syndrome (3). Half of
these events occurred after the first of three required
vaccine doses [19]. In addition, there is one case report
that describes the occurrence of PTS following recombin-
ant DNA (deoxyribonucleic acid) hepatitis B vaccination
(which consisted of 20 μg of the purified HBsAg) [20].
There are also reports that describe PTS following vari-
ous other vaccinations, such as influenza [21,22], human
papilloma virus [23,24], DPT (diphtheria, pertussis, tet-
anus) [22,25,26], swine flu [27] and tetanus [22,28]. Simi-
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overview of the micro-organisms that have been associ-
ated with PTS, based on Stek et al. [29] and augmented
with recent studies [29,30].
To our knowledge, this is the first case report describ-
ing the occurrence of Parsonage-Turner syndrome fol-
lowing the administration of post-exposure prophylaxis
against possible infection with HIV and hepatitis B.
Similarly to the cases previously described [19,20], the
HBV vaccination most likely caused PTS in our patient.
Non-operative treatment is the standard treatment, and
although the outcome is typically preferable, almost a
third of the patients suffer from residual complaints after
six years.
Patient consent
“Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor of this journal”.
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